IntroDuctIon
hESCs can be manipulated to generate defined neuronal and glial lineages, thereby offering a major opportunity to study neuro development and model neurological disease in vitro, as well as potentially having direct therapeutic applications in the field of regenerative neurology. However, certain challenges remain before the promise of hESCs for neurological diseases can be fully realized, including the need to optimize survival, fate and function of neural derivatives upon both neural conversion and longterm differen tiation in vitro and in vivo [1] [2] [3] [4] . Current protocols for the derivation of neural precursor cells (NPCs) from ESCs recommend defined conditions; however, these conditions lead to significant cell death, in which the production of reactive oxygen species (ROS) has a central role [5] [6] [7] [8] [9] . Thus, neuralization protocols often contain anti oxidants (which may increase the propensity to accumulate genetic mutations), involve coculture with stromal feeder layers or use B27 and/or N 2 supplements 2, 6, [8] [9] [10] [11] [12] [13] . ROS generation can potentially be decreased by culture at a low physiological oxygen level (3%), which is closer to that found in the developing embryo and the adult brain 9, 14, 15 . There are a number of reports of the beneficial effects of lowoxygen tensions in enhanc ing the survival, proliferation and longterm maintenance of vari ous stem cell and neuronal populations, and oxygen also appears to be a critical component of the stem cell niche 8, 9, 12, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . Furthermore, low oxygen promotes the generation of dopaminergic neurons from midbrain NPCs and oligodendrocyte differentiation from human fetal NPCs [25] [26] [27] [28] [29] , leading to the suggestion that oxygen func tions as a developmental morphogen 16 . The cellular response to low oxygen is coordinated by three hypoxiainducible factors (HIFs), and both HIF1α and HIF2α have been implicated in NPC and neuronal survival at low oxygen 1, 18, [29] [30] [31] . However, it is likely that HIF independent pathways also have a role 9, 32 .
By contrast, it is becoming increasingly clear that the more tradi tional stem cell systems using oxygen levels approximating room air (20%) are far from optimal, particularly with regard to neural speci fication and differentiation 8, 9 . Thus, this protocol has been designed to generate NPCs and their regionally specified derivatives from hESCs using a physiological oxygen level of 3% (normoxia) 31 .
Overview of this protocol
The protocol involves the induction of NPCs from hESCs, main tained either in feederbased or feederfree conditions, in a chemi cally defined, serumfree medium. hESC colonies are enzymatically detached and transferred to a lowoxygen incubator (3% O 2 ) in which they are grown in suspension culture in the absence of pluripotencymaintaining factors activin and fibroblast growth factor (FGF)2. Cells acquire a neuroepithelial identity within 2 weeks, and can then be expanded with FGF2 or directed to dif ferentiate toward midbrain dopaminergic neurons or spinal motor neurons by the sequential application of Shh agonists and either FGF8 or retinoic acid (RA) 7, 10, 33, 34 , respectively. NPCs are terminally differentiated on polydlysine (PDL)/laminincoated cover slips in a basic medium of DMEM, 2% (vol/vol) B27 and 1% (vol/vol) antimycoticantibiotic solution, in which they can be maintained for many months without the addition of growth factor supple ments such as brainderived neurotrophic factor (BDNF) or glial cell-derived neurotrophic factor (GDNF). Confirmation of func tional neuronal maturity can be demonstrated with electrophysio logical recordings.
Comparison with other protocols
Standard neuralizing protocols established at 20% O 2 have reported a 2week time course for the acquisition of a neuroepithelial Efficient derivation of NPCs, spinal motor neurons and midbrain dopaminergic neurons from hESCs at 3% oxygen identity 7, [33] [34] [35] . Reports of an interaction between HIF2α and Oct4 might suggest that this would be delayed at low oxygen 19 , but we also report NPC generation over 14 d (ref. 31) . Furthermore, survival of NPCs is significantly greater when neural conversion is performed at 3% O 2 , reducing the technical difficulties of the procedure 9, 31 . This effect is particularly marked when using a fully chemically defined and serumfree medium as described here, which at 20% O 2 typically results in the death of >90% of NPCs 9 . Other protocols circumvent this survival challenge by including anti oxidants (increasing the propensity to acquire genetic mutations), supplements, such as B27 or N 2 , or undefined components, such as knockout serum replacement, stromal feeder layers or Matrigel (an animal product derived from a mouse sarcoma line) 2, 7, [10] [11] [12] . Our protocol has the added advantage of using feederfree hESCs, maintained on plates coated with mouse embryonic fibroblast (MEF) medium (nonconditioned) 36 , thereby removing potential contamination from MEFs themselves and, once again, avoiding the use of Matrigel. It works equally well for hESCs maintained on feeders. Unlike several other protocols, our method of neural conversion does not involve an embryoid body step, where, in the absence of defined conditions (serum is often present), large, often cystic, bodies containing all three germ layers are formed, thus requiring a later, somewhat technically challenging, mechanical selection step for neural rosettes 2, 7, 10 . This protocol is suspension culture-based throughout (until terminal differentiation). To avoid the need for daily pipetting, which is advised in some protocols, we recommend the use of an orbital shaker to prevent adherence to the base of the culture dish 10, 35 . A further refinement of our protocol is the use of a McIlwain tissue chopper to passage the NPCs. This generates many small, similarly sized fragments in a short period of time (5-10 min per plate), thereby avoiding the genetic instability associated with enzymatic passaging (although this tendency is also decreased in cultures at low oxygen) and replacing the potentially timeconsuming use of flamepulled Pasteur pipettes 7, 37, 38 . Finally, we demonstrate that directed differentiation toward spinal motor neurons and midbrain dopaminergic neurons is markedly enhanced at 3% compared with 20% O 2 (ref. 31) . Although this does not appear to have been previously studied in motor neurons, this effect is entirely consistent with studies on rat, mouse and human mesencephalic neural precursors, report ing enhanced survival and improved generation of dopaminergic neurons at 3% O 2 (refs. 25-28) .
Applications
This protocol enables the generation of human NPCs for in vitro and in vivo experiments, encompassing a wide range of neural develop mental studies as well as neurodegenerative disease modeling and cellbased therapies. The key feature is the use of a lowoxygen envi ronment, which provides a novel and more physiologically relevant system. Furthermore, there is broad scope to adapt this method to allow disease modeling, using induced pluripotent stem cells derived from patientspecific fibroblasts as the starting material. This will be of particular relevance to neurodegenerative diseases in which ROS are proposed to have a key role, because it will allow investigation of the mechanisms of neural degeneration and test ing of potential neuroprotective agents to be undertaken in a more appropriate environment 30, 39, 40 . We also predict that this protocol will have applications for cellbased therapies, overcoming the oxy gen challenge represented by culture at 20% O 2 and transplantation into a much lower oxygen environment, which can be as low as <1% for dopaminergic neurons in the midbrain 16 .
Limitations
The main limitation of this protocol is the requirement for a low oxygen environment in which to undertake the cultures. We have used a lowoxygen, triplegas incubator in which oxygen is dis placed by nitrogen; however, it should also be possible to use an oxygendepletion flush box or chamber, filled with a premade gas mixture with the desired composition of O 2 , N 2 and CO 2 and sealed before placement inside a standard incubator 41 . One advantage of the lowoxygen incubator over the oxygendepletion chambers is that it allows room for an orbital shaker, which removes the need for daily pipetting to release spheres that have adhered to the culture vessel 10, 35 . Both of these lowoxygen systems can be used in conjunction with an enclosed glove box when removing cells for feeding, passaging and other standard cell culture routines. Alternatively, full 'hypoxic' workstations are now available; these maintain a constant gaseous environment throughout, but they incur a considerable expense. However, changes in oxygen tension during cell culture routines are not a major problem when using a lowoxygen incubator because, although oxygen equilibration in the gaseous phase above the medium is complete within 15 min for a 10cm dish (~55 min for a T75 flask), it takes ~3 h for oxygen to dissolve in the medium 42 . The fact that the cells are unaffected by periodic exposure of the culture vessels to room air is reflected in our observations of enhanced survival of NPCs at 3% O 2 ; down regulation of HIF1α followed by maintenance of HIF2α (and no reappearance of HIF1α); stable electrophysiological properties of neurons removed from the lowoxygen environment for several hours of recordings; and establishment of longterm differentiated neural cultures in a basic medium of DMEM and 2% (vol/vol) B27, without the requirement for supplements such as GDNF, BDNF, insulinlike growth factor, cAMP or ascorbic acid. The possibility of changes in oxygen tension can be further minimized by allowing the medium to equilibrate in the lowoxygen incubator for several hours prior to feeding 43 . 
Experimental design
The most important factor determining the efficiency of neural conversion is the quality of the starting material-the hESC colo nies. Following thawing, we recommend culturing the cells for at least two passages (Steps 1 and 2) before attempting the neural induction protocol (Steps 3-22). Obtaining cells with low passage numbers is less important than the quality of the colonies, which should have welldefined edges and an undifferentiated appearance, confirmed by uniform staining for pluripotency markers such as OCT4 and SOX2 ( Fig. 1) . Detailed procedures for culturing hESCs are discussed elsewhere 36, 44 . The neural induction process is based on the default model of neural conversion 5 through which the removal of pluripotency maintaining factors and maintenance in a defined environment (the absence of BMP signaling) allows the acquisition of a neural fate. The addition of BMP antagonists such as SB431542 (activin inhibitor), which increases the speed of neural conversion at 20% O 2 (ref. 45) , results in smaller numbers of NPCs at low oxygen (S.R.L.S. and B.B., unpublished observations), and is therefore not included in the protocol. The method is suspension culturebased throughout ( Fig. 2) , with the first step being enzymatic detachment of hESC colonies with Liberase (highly purified collagenase I and II plus dispase), which are then propagated as spheres in defined conditions, acquiring a neural identity (98.7 ± 0.5% SOX1positive, 97.4 ± 0.3% nestinpositive and 1.1 ± 0.7% OCT4 positive; Fig. 3 , panel a) over 2 weeks; this timescale is comparable to that observed at 20% O 2 (refs. 7,33,35,45) . This contrasts with embryoid body-based differentiation protocols, requiring a later mechanical selection of neural rosettes. Equally, neural conversion involving adherent culture also typically requires a selection step for neural rosettes 2, 7, 10, 11 . By performing neural induction in a low, more physiological oxygen environment, cells are protected from the significant stresses associated with neural conver sion, reported in defined conditions at 20% O 2 (refs. 6,8,9) . Over the first 7-10 d, the number of cells remains fairly static, reflecting adaptation to the lowoxygen environment, because the embryonic stem (ES) cultures are maintained at 20% O 2 ; this is supported by the appearance and subsequent disappearance of HIF1α protein over 6 d (Fig. 3b,d) .
Coinciding with the stabilization of HIF2α, and following the addition of FGF2, the spheres grow rapidly and should now appear phasebright with welldefined edges and few dead cells ( Fig. 3b-d) . The original seeding density at 200,000 cells per ml is important-if it is too low the cells will die, whereas if it is too high paracrine signaling may interfere with neural conversion. Equally, the initial chopping of the ES colonies into small pieces is required, because larger spheres tend to demonstrate a lower efficiency of neural conversion 35 . As the spheres grow, it is necessary to break them into smaller ones, so that all cells are accessible to nutrients and growth factors; passaging is performed mechanically to reduce the chance of developing genetic mutations, which is a recognized risk in enzymatically propagated cells but is further decreased by expanding the NPCs at low oxygen (ref. 12) .
NPCs can be terminally differentiated from day 28 onward (Step 27A(i-iii); electrophysiology (wholecell recordings in currentclamp mode), demonstrating immature appearing action potentials at 10 d, and spontaneous action potentials by 30 d, along with the expected relation ship between current injection and action potential frequency that is characteristic of functional neurons 46 . Similarly to early reports of NPC differentiation at 20% O 2 (refs. 35,47) , early NPCs (before day 50) differentiated at 3% O 2 generate mainly neurons, whereas those plated after longer periods in cultures tend to yield fewer neurons and more astrocytes, which resembles in vivo development in which neurogenesis precedes gliogenesis. A few oligodendrocyte marker 4 (O4)positive oligodendrocytes are also observed at later time points (Fig. 4f) .
Day 14 NPCs generated at 3% O 2 can be specified into spinal motor neurons or midbrain dopaminergic neurons by adapting previously published protocols developed at 20% O 2 (ref. 33 ). Thus, the sequential addition of RA to caudalize the NPCs, followed by the combination of RA and the Shh agonist PM to ventralize them, results in the induction of OLIG2expressing cells that differentiate into HB9positive motor neurons, and mature to express choline acetyltransferase (ChAT) (Fig. 5) . OLIG2 induction is twofold greater at 3% than at 20% O 2 . Similarly, sequential application of FGF8 and then FGF8 plus purmorphamine (PM) results in the induction of EN1 and tyrosine hydroxylase (TH)positive neurons that mature to express MAP2 and vesicular monoamine transporter (VMAT) (Fig. 6) . EN1 induction is enhanced fivefold ) and 20 µl monothioglycerol (450 µM) with or without 5 ml antimycoticantibiotic solution (1% vol/vol). Filter through a 0.22µm filter and store at 4 °C for up to 10-14 d. Plating medium for terminal differentiation of NPCs (50 ml) In a sterile environment, prepare 48.5 ml DMEM, 1 ml B27 (2%, vol/vol) and 0.5 ml of antimycoticantibiotic solution (1%, vol/vol). This can be stored at 4 °C for 7-10 d. Electrophysiology solutions Internal solution consists of 130 mM potassium gluconate, 4 mM NaCl, 10 mM HEPES, 10 mM BAPTA, 4 mM MgATP, 0.5 mM Na 2 GTP, 0.5 mM CaCl 2 and 2 mM Lucifer yellow dipotassium salt (pH adjusted to 7.3 with KOH). This can be stored at − 20 °C for up to 2 months. External solution contains 144 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 1 mM NaH 2 PO 4 , 2.5 mM CaCl 2 , 10 mM glucose and 2 mM MgCl 2 ; pH is adjusted to 7.35 with NaOH. This solution should be prepared freshly before each recording session. Activin (10 mg ml − 1 ) Dissolve 10 µg in 1 ml PBS with 0.1% (wt/vol) BSA. Store at − 80 °C in 50µl aliquots for up to 6 months. Once it is thawed, store at 4 °C and use it within a week. Collagenase (50 ml) Dissolve 50 mg of collagenase IV in 50 ml of chemically defined medium (CDM) to prepare a concentration of 1 mg ml − 1 . This can be warmed at 37 °C to speed up the dissolving process. Filter through a 0.22µm filter. The solution can be stored at 4 °C for up to 7 d, but the activity is best when it is freshly prepared. FGF-2 (20 mg ml − 1 stock) Dissolve 100 µg of FGF2 in 5 ml sterile PBS with 0.1% (wt/vol) BSA. Store in 100µl aliquots for up to 6 months at − 80 °C; once it is thawed, store it at 4 °C and use it within a week. to 62.5 µg ml − 1 ) in CDM.  crItIcal Liberase activity varies between batches; therefore, the optimal working dilution will need to be redetermined for each batch. PFA (4% (wt/vol), 100 ml) Measure out 4 g of PFA into a 100ml glass bottle. Add 100 ml of 1× PBS. Place on a hot plate at 60 °C and add a magnetic stirrer. Add 1-2 drops of 5 M sodium hydroxide, cover with foil (do not screw on the lid), label and leave it for 10-30 min to dissolve. Use HCL (2 M) to adjust the pH of the solution to a value between 7.2 and 7.4. Filter (0.45µm pore) into two 50ml conical tubes and, once it has cooled, store it at 4 °C. Use within 7 d. ! cautIon PFA is toxic and should be prepared in a fume hood; wear a lab coat, gloves and eye protection.  crItIcal Do not allow the solution to boil. Once it is thawed, use it within 7 d. ! cautIon Do not expose it to light. Wear appropriate laboratory protective equipment, including gloves. Retinoic acid (100 mM stock) Dissolve 50 mg of RA in 1.67 ml of DMSO. Store in 50µl aliquots at − 80 °C, in a container protected from the light (e.g., cover with foil). Working stock (1 mM) can be stored in the dark at − 20 °C for 1 month: dilute a 100 mM aliquot with 100% ethanol. Once thawed for use, an individual 1 mM aliquot can be stored (in a dark container) at 4 °C for up to 1 week. ! cautIon RA is a powerful morphogen and can be absorbed through the skin; therefore, special care should be taken when working with RA during pregnancy. Gloves should be worn and any spillages cleared up immediately.  crItIcal RA activity is destroyed by exposure to the light, and thus aliquots should be prepared with the lights turned off in the hood and then stored in dark containers.
MaterIals

REAGENTS
• • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • • Sterilin
Poly-D-lysine
EQUIPMENT SETUP Poly-L-ornithine-and laminin-coated cover slips First, prepare the cover slips. Place the 13mm glass cover slips into a glass beaker and cover them fully with methanol; leave overnight on a shaker to gently agitate the cover slips. Pour off the methanol and rinse thoroughly with water several times and then arrange the cover slips on filter paper in a stack in a glass dish and autoclave; the cover slips can then be stored until required. In a sterile hood, place one cover slip into each well of a 4 or 24well plate. This can be done using sterile tweezers or with a glass Pasteur pipette attached to suction. Next, cover each cover slip with 300 µl of 20 µg ml − 1 PDL and check that none of the cover slips are floating. Replace the lid and leave in the hood overnight. The next day, aspirate the PDL and rinse cover slips three times with sterile water. Leave them in the hood with the lid off until they are completely dry (2-4 h). Carefully add 50-60 µl of laminin to the center of each cover slip and gently transfer them to the incubator at 37 °C, for a minimum of 1 h.  crItIcal Be sure to wash the cover slips with sterile water rather than with PBS, as the latter forms crystals when it dries.  crItIcal Do not allow the laminin to spill off the edge of the cover slip or dry out. proceDure culture and expansion of hescs • tIMInG 10-14 d 1| Grow hESCs in feeder-free conditions on 6-cm or 10-cm Corning plates with 3 ml or 6 ml of CDM supplemented with 12 ng ml − 1 FGF-2 and 10 ng ml − 1 activin A. Alternatively, grow hESCs on irradiated mouse embryonic fibroblasts, supplementing the CDM with 10 ng ml − 1 FGF-2, 10 ng ml − 1 activin and 10 ng ml − 1 insulin. Exchange medium daily.
2|
Passage approximately every 5-7 d by incubating with 1 mg ml − 1 collagenase for 5-10 min. Replace collagenase with CDM and remove colonies by gently scraping with the tip of a 5-ml pipette. Centrifuge at 132g for 3 min, remove the supernatant and resuspend in FGF-2 and activin-supplemented CDM; split 1:5 to 1:10, depending on confluence at time of passaging. Alternatively, passage Hues ES cells as single cells, with 0.05% (wt/vol) trypsin-EDTA for 3-5 min, inactivate with serum and complete passage as above.
preparation of es cells for neural conversion • tIMInG 1.5-4 h 3| Allow the hESC colonies to grow almost to confluence; this is usually a day longer than the point at which they would be passaged. 
5|
Aspirate the ES medium and add 2 ml of freshly prepared Liberase (62.5-125 µg ml − 1 ) to each 10-cm plate; use 1 ml for a 6-cm plate. Return to the incubator at 37 °C for 10-30 min. Review every 5 min to check whether colony detachment has commenced.  crItIcal step The Liberase must be freshly prepared. ? troublesHootInG 6| Once at least half of the colonies are floating, swirl the plate to aid detachment and transfer contents to a 15-ml conical tube. Combine the colonies from two 10-cm plates or three 6-cm plates into one 15-ml conical tube.
7|
Tilt the plate and rinse off remaining colonies by forcefully pipetting 2-3 ml of CDM once across the plate; add to the conical tube. This step can be repeated once or twice until all or almost all of the colonies have been collected. Sometimes all the colonies come off together as one sheet; simply transfer them to the conical tube.  crItIcal step Do not pipette the colonies more than once on any one occasion because this breaks them up into single cells, which show poor survival on neural conversion.
8|
The majority of colonies will settle to the bottom of the conical tube by gravity. Allow 3-5 min for this and aspirate as much of the supernatant (containing the Liberase) as possible, leaving around 1 ml.  crItIcal step Be very cautious if considering centrifuging the cells at this point because it causes cell lysis; if necessary, try 0.5g for 2 min.
9| Rinse the cells gently, to remove the Liberase, with a further 6-8 ml of CDM per conical tube and allow to settle by gravity.  crItIcal step It is important not to miss out this step; otherwise, residual enzymatic activity will remain and the neuralizing procedure will fail.
10|
Remove all but 1 ml of the supernatant and transfer the colonies from one 15-ml tube onto the upturned lid of one of the 6-cm Corning plates, forming a circle 1-2 cm across. Use a rubber bulb and glass Pasteur pipette for this, and transfer as little medium as possible. Next, remove as much medium from the edges of the circle as possible with a P10 pipette. Spread the cells out a little with the pipette tip.  crItIcal step The cells must be as dry as possible prior to chopping, but they should not be allowed to dry out.
11|
Place the colonies on the chopper and chop at 120-µm distances.
12|
Rotate the plate by 90° and chop a second time.
13| Use a P1000 pipette and 1 ml of CDM to transfer the chopped colonies to a 50-ml conical tube. Rinse the plate several times until almost all of the colonies have been transferred.
14|
Repeat Steps 10-13 with the settled colonies in the other conical tubes.
15|
Transfer the cells to low adherence T75s, and place flat in the 3% O 2 incubator. As a rough guide, cells from two 10-cm plates or three 6-cm plates can be combined into one T75 containing 10 ml of CDM. For greater accuracy, take a proportion of cells (e.g., 2 ml of 20 ml chopped-colony suspension), dissociate with Accutase and perform a cell count with a hemocytometer; next, seed the remaining cells at ~200,000 cells per ml of CDM. 17| Leave the cultures for 48 h (day 2) and then add 9 ml of warm CDM to each flask (equivalent to a 50% medium change).
18|
On day 4, tap the flasks to dislodge any attached spheres and transfer the medium and spheres from each flask into a 15-ml conical tube and allow to settle. If the spheres are very small, they can be centrifuged at 1.2g for 1 min. Aspirate down to 3-4 ml. Resuspend in 10 ml of CDM and transfer to fresh T75s.
19| Add 9 ml of warm CDM on day 6.
20|
On day 8, tilt the T75s and allow the spheres to settle in one corner. Remove most of the medium (taking care not to suction the spheres) and add 8 ml fresh CDM.
21|
On day 10, settle the spheres in 15-ml conical tubes. Chop at 120 µm in three directions, as described in Steps 10-12.
Resuspend in 10 ml of CDM, transfer to 9-cm Sterilin Petri dishes (in a 1:1 ratio with the contents of one T75) and place on an orbital shaker to prevent aggregation. The orbital shaker should be set to ~40 r.p.m.
22|
On day 11 or 12, supplement the medium directly with 20 ng ml − 1 FGF-2 plus 5 µg ml − 1 heparin to promote proliferation.
Maintaining npc cultures
• tIMInG 14-100 d 23| Feed the cells every 2-3 d by transferring the spheres to a 15-ml conical tube, allowing them to settle by gravity and performing a 70% medium change with CDM supplemented with 20 ng ml − 1 FGF-2 plus heparin 5 µg ml − 1 . NPC cultures can be easily maintained in this way for over 100 d. ) directly to the plate and replace on the orbital shaker (Fig. 6) .  crItIcal step Ideally, spheres should be mechanically passaged 3-5 d before plating for differentiation so that they are reasonably small when plated as whole spheres; this allows room for proliferation after plating. (vi) Plate cells for differentiation at any point between day 28 and day 35, as described in Step 27A(i-iii).
neuronal electrophysiology • tIMInG 4-8 h 28| Neurons can be patched at any stage after plating, but optimal recordings are obtained after ~30 d of differentiation. Prepare internal and external solutions (see REAGENT SETUP) and glass microelectrodes with 3-6 MΩ resistance to record from neurons in whole-cell current-clamp mode. A detailed description of the procedures involved in performing whole-cell current-clamp recordings from neurons is provided elsewhere 48, 49 .
? troublesHootInG Troubleshooting information can be found in table 2. 6. When required, thaw rapidly in a water bath at 37 °C and add to 9 ml of CDM. 7. Centrifuge at 132g for 2 min and remove all the supernatant (containing DMSO). 8. Resuspend in 10 ml of fresh CDM with 20 ng ml − 1 FGF-2 plus 5 µg ml − 1 heparin; transfer to a 9-cm Sterilin Petri dish and place it on the shaker in the low-oxygen incubator. 9. Exchange medium the following day to remove any dead cells. Thereafter, feed every 2-3 d and passage mechanically as required.
Box 2 | FREEZING AND THAWING NPCS
? troublesHootInG (Fig. 4) . Regional specification of day 14 NPCs with RA should induce expression of caudal genes including HOXB4, and subsequent application of Shh agonists should direct these spinal NPCs toward motor neuron precursors that express OLIG2 and NKX6.1. Terminal differentiation should generate HB9 and β-III tubulin-positive motor neurons by 48 h, and by 10 d, ChAT will start to be expressed (Fig. 5) .
Directed differentiation of day 14 NPCs by sequential application of FGF-8 and Shh agonist should induce expression of the midbrain dopaminergic genes NURR1, PITX3 and EN1. Terminal differentiation should generate EN1 and TH co-positive neurons after 2-10 d, with the number of TH-positive neurons increasing with time in culture. TH-positive neurons mature to express MAP2 and VMAT (Fig. 6) . 
